Latest News

Epilepsy community seeks redefinition of bioequivalence from FDA

For several years, epilepsy practitioners have questioned the U.S. Food and Drug Administration?s (FDA) definition of bioequivalence as it applies to narrow therapeutic index (NTI) drugs, such as those used for epilepsy. In response to these concerns, the FDA has sponsored 3 studies of antiepileptic drugs and also convened an advisory board to help determine which drugs are NTI.
View full story

Post your comment.


  • Scientists build a digital piece of a rat's brain

  • Machines have nothing on mom when it comes to listening

  • New clues about how humans become tool users

  • Researchers learn how to grow old brain cells

  • Frequent school moves hurt low-income childrens' math scores

  • More 'global' individuals contribute less

  • Popular crime shows may help reduce sexual assault

  • 'Blind analysis' could reduce bias in social science, biology research

  • Unexpected connections: Calcium refill mechanisms in nerve cells affects gene expression

  • Preventing memory loss before symptoms appear